Open Access Open Access  Restricted Access Access granted  Restricted Access Subscription or Fee Access

Vol 17, No 2 (2019)

Articles

MOLECULAR PATHOGENESIS AND MARKERS FOR RENAL CELL CARCINOMA

Shirshova A.N., Boyarskikh U.A., Filipenko M.L., Pokrovsky V.S., Kushlinskii N.E.

Abstract

The review highlights current data on molecular pathogenesis and potential markers of clear cell renal cell carcinoma, obtained in MultiOmyx studies. Key molecular mechanisms of the pathogenesis of RCC are the loss of functions of the VHL, PBRM1, SETD2, BAP1, KDM5C and CDKN2A genes and the activation of the PI3K-AKT-mTOR cascade. In 91% of cases of sporadic renal cell carcinoma, one VHL allele is lost as a result of deletions of the 3rd chromosome short arm. In 55% of cases, the second VHL allele is inactivated due to somatic mutations. As a result, HIF1-dependent transcription of hypoxia adaptation genes, including VEGF-A, is activated in the cell. Loss of functions of the PBRM1, SETD2, BAP1 and KDM5C genes leads to disruption of chromatin remodeling processes. All genes, with the exception of KDM5C, are located near the VHL gene on the 3rd chromosome. Inactivation of the CDKN2A disrupts the cell cycle control. The pathological activity of the PI3K-AKT-mTOR cascade induces the synthesis of proteins promoting cell division, growth, and survival. Anti-angiogenic and anti-mTOR therapy is the standard treatment for metastatic kidney cancer. Objectively about 40% of patients respond to therapy. Most cases form secondary resistance after 1-1.5 years of successful therapy. Challenge of personalized therapy and prognosis actualize the problem of searching for RCC molecular markers. To date, none of the promising markers, including the key molecules of the RCC pathogenesis and target therapy targets, are recommended for use in clinical practice.
Molekulyarnaya Meditsina (Molecular medicine). 2019;17(2):3-18
pages 3-18 views

MOLECULAR AND EPIGENETIC FACTORS IN THE SCHIZOPHRENIA DEVELOPMENT

Erichev A.N., Bode I.I., Polyakova V.O., Kotsyubinsky A.P.

Abstract

Schizophrenia is a severe psychiatric disorder with etiology not clearly determined yet. Scientists associate its development with various factors including excessive expression of some genes and unstable social environment. The World Health Organization estimates the prevalence of schizophrenic spectrum disorders as 21 million people worldwide. Moreover, some researchers note that such symptoms as paranoid thinking and hallucinations in a mild form can occur in 5-8% of the healthy population. This fact complicates the process of making the diagnosis. Laboratory tests or imaging methods that could accurately determine the presence of the disorder are yet to be developed as of today. In addition, the disorder can manifest in different ways which makes it difficult to assess the diagnosis reliability and prognosis. The dopamine hypothesis of schizophrenia was very popular previously, however, now it is gradually receding into the past giving the way to new, more progressive biopsychosocial and diathesis-stress hypotheses. In this article, the main factors that influence the schizophrenia development are considered. A better understanding of the disease pathogenesis may allow developing better diagnosis methods and more effective therapeutic approaches.
Molekulyarnaya Meditsina (Molecular medicine). 2019;17(2):19-22
pages 19-22 views

EPIGENETIC REGULATION OF REVERSE CHOLESTEROL TRANSPORT: THE ROLE OF MICRO-RNAS

Aitbaev K.A., Tuhvatshin R.R., Fomin V.V., Murkamilov I.T., Talaibekov M.T.

Abstract

Micro-RNAs are a group of small non-coding RNA molecules regulating target genes at the post-transcriptional level. Micro-RNAs are involved in the control of many pathophysiological processes, including dyslipidemia, the main risk factor for atherosclerosis. Current evidence suggests micro-RNAs to be a new class of epigenetic regulators controlling the metabolism of high-density lipoprotein cholesterol (HDL-C), which makes a significant contribution to the pathophysiology of atherosclerosis. Accumulated data suggest micro-RNA, in particular, miR-33, miR-27, miR-144, miR-758 and miR-20, to be involved in the post-transcriptional control of ABCA1, ABCG1 and SCARB1 genes regulatory network of the reverse cholesterol transport (RCT). These micro-RNAs have been shown to be central players in disrupting the path of RCT, leading to the development of atherosclerosis. This article presents the latest data on the participation of the corresponding micro-RNA at different stages of both HDL metabolism and the pathway of RCT. Some of the limitations on the therapeutic potential of micro-RNA and the prospects for transferring to the clinical plane the results of experimental studies on their participation in the regulation of RCT are also discussed.
Molekulyarnaya Meditsina (Molecular medicine). 2019;17(2):23-30
pages 23-30 views

STUDY OF EXPRESSION OF MMP-1 GENE IN LOCALIZED SOLERODERMIA

Nevozinskaya Z.A., Soboleva A.G., Klimov E.A., Korsunskaya I.M., Sobolev V.V.

Abstract

The aim of the study was to investigate the expression of the MMP-1 gene in patients with a diagnosis of localized scleroderma. Methods. The study included 12 patients with an established diagnosis of localized scleroderma. The material of the study consisted of biopsies from the affected and uninfected areas of the skin. As a control in the work, biopsies of the same patients from unaffected areas of the skin were used. The analysis was carried out by real-time PCR. The statistical processing of the results was carried out by the 2-ΔΔCt method. Results. The values of the relative expression levels of the gene were obtained in all patients. Individual analysis of each patient showed the expression level of the MMP-1 gene in scleroderma affected skin to be lowered comparatively with the visually unaffected skin (control) in the range from 4.2 times to 20.8 times. The average value of the change in the expression level of the gene was reduced by 7.6±2.6 times. Patients were divided into two groups - with a limited plaque form and a common plaque form of scleroderma. In patients with a limited form of the disease, expression of the MMP-1 gene was shown to be significantly reduced by 5.3 times, and in patients with a common form of the disease it was reduced by 11-fold times. Conclusion. A quantitative measurement of the expression of the metalloproteinase-1 gene (MMP-1) by PCR-RT was performed. Experimentally there was showed a decrease in gene expression in scleroderma affected skin compared to unaffected skin.
Molekulyarnaya Meditsina (Molecular medicine). 2019;17(2):31-38
pages 31-38 views

ACTIVATING POINT MUTATION OF BRCA1/2 GENES IN AZERBAIJAN POPULATION

Aliyev J.A., Melikova L.A., Mansurov E.B., Aliyeva F.K., Bagirova E.E., Mexdizade S.Q., Nadjafova A.S.

Abstract

Introduction. Breast cancer is the leading cancer type among woman of Azerbaijan population. Hereditary mutations of the BRCA1/2 genes are considered as high risk for appeared breast and ovarian cancers. In Azerbaijan BRCA1/2-related breast and ovarian cancer were not investigated. Aim. The study is focused to detect BRCA1/2 germline mutation-associated breast and ovarian cancer in the Azerbaijan population. Method. DNA isolation from peripheral blood samples was performed with «colon» method. Detection of BRCA1/2 mutation was conducted using allele - specifics PCR and allele - specifics primers. Results. BRCA1_5382insC, BRCA1 5622T, BRCA1_185delAG and BRCA2_ 6174T mutations were more spreading point mutations among the breast and ovarian cancer patients. BRCA2 9254 del5 mutationin BRCA2 gene could not be detected using method and primers. Conclusion. Allele - specifics PCR and allele - specifics primers that were used in this study can be effectively used for the selection of BRCA1/2-related breast and ovarian cancer.
Molekulyarnaya Meditsina (Molecular medicine). 2019;17(2):39-43
pages 39-43 views

OPTIMIZATION OF THE METHOD OF THE MULTI-TARGET SINGLE-BASE ELONGATION FOR THE DETECTION OF SOMATIC MUTATIONS IN MALIGNANCIES

Musaelyan A.A., Chistyakov I.V., Nazarov V.D., Lapin S.V., Sogoyan M.V., Khalchitsky S.E., Emanuel W.L., Lobachevskaya T.W., Akopov A.L.

Abstract

Background. Genotyping of the tumor samples is necessary for a personalized approach in the treatment of patients with malignancies. The identification of somatic mutations in EGFR and KRAS genes can help to predict the course of the disease and to individualize the therapy. One of the methods for detecting somatic point mutations in EGFR and KRAS genes is the multi-target single-base elongation (MSE). Objective. To optimize MSE for the detecting clinically significant aberrations in the EGFR and KRAS genes in the tumor samples. Material and methods. DNA was isolated from 31 samples of non-small cell lung cancer, 9 of which were formalin-fixed and paraffin embedded (FFPE). Laboratory characteristics of the MSE were compared with such one of real-time PCR, digital PCR, and Sanger sequencing. 44 Results. Protocol for verification the aberrations in the EGFR and KRAS genes has been created. The sensitivity of MSE was determined (48 copies/ßl of the mutant DNA). The laboratory characteristics of the method were shown to be comparable with such one of real-time PCR. MSE is able to detect aberrations in FFPE tissue samples. MSE can detect more point mutations in comparison with Sanger sequencing: 26 vs 3%, respectively. Conclusion. MSE is a highly sensitive and relatively rapid multiparametric method of genotyping a tumor tissue.
Molekulyarnaya Meditsina (Molecular medicine). 2019;17(2):44-49
pages 44-49 views

MOLECULAR MECHANISMS OF RETARDATION OF SKIN AGING UNDER INFLUENCE 0F HUMAN PLACENTA HYDROLYSATE

Kvetnoy I.M., Drobintseva A.O., Kleimenova T.S., Polyakova V.O., Turkadze K.A.

Abstract

Introduction. Application of placenta hydrolysate in cosmetology opens a new page in anti-aging therapy. Numerous studies have confirmed the antioxidant, anti-inflammatory, anti-pigmental properties of placenta hydrolysate preparations, as well as activation of trophic function and optimization of cellular metabolism. The difference between preparation Melsmon and its analogs is the maximum safety of the drug since it does not include hormones, growth factors, enzymes, it is completely free from toxic substances. Purpose of the study. To evaluate the possibility of using the preparation Malsmon as a regulatory and geroprotective agent for the prevention of skin aging of human fibroblasts during their senescence in vitro Methods. The expression of proteins was compared by immunocytochemistry in cell cultures of human skin fibroblasts at 7th and 14th passages with the administration of preparation Melsmon and in the control group. Results. When analyzing the data of the relative area of expression of the studied markers in the «young culture» of human fibroblasts, an increase in the expression indices of Ki-67, calreticulin, sirtuin-6 andsyntaxin under the influence of the Melsmon preparation was found after the 3rd passage. Whereas in the «old culture» on the 14th passage, when placental hydrolysate (Melsmon) was added, activation of the expression of ki-67, sirtuins 1 and 6, to the same level as in the young (control) culture was observed. Conclusion. The Melsmon preparation has pronounced geroprotective properties with respect to human skin cells, which gives arguments for its further development as a means of stimulating regenerative processes in the skin and preventing its aging.
Molekulyarnaya Meditsina (Molecular medicine). 2019;17(2):50-56
pages 50-56 views

THE SOME PECULIARITIES OF CAPSULAR FORMATION AFTER IMPLANTATION OF SILICONE WITH ADSORBED MULTIPOTENT MESENCHYMAL STROMAL CELLS

Maiborodin I.V., Mikheeva T.V., Kuzkin S.A., Maiborodina V.I., Kadyrova A.I., Shevela A.I.

Abstract

Introduction. The widespread cellular technologies will sooner or later lead inevitably to the introduction of multipotent mesenchymal stromal cells (MMSC) or their exosomes to patients who have implanted artificial materials in their organism. The engraftment of foreign bodies is accompanied first by the acute and then chronic inflammation, very often acquiring a granulomatous character. A decrease in the activity of the inflammatory response can theoretically improve the results of implantation. Aim. To study the possibility of using autologous MMSC of bone marrow origin (AMMSCBMO) for the influence on the integration process of a silicone implant in the experiment. Methods. The condition of the capsule and tissues around the implanted silicone with adsorbed AMMSCBMO with a transfected GFP-gene and membranes stained by Vybrant® CM Dil was studied by methods of light microscopy with using luminescence. Results. When studying the thickness and vascularization of a capsule formed from dense fibrous connective tissue to delimiting the silicone implanted in the organism, no significant differences were found related to the adsorption of AMMSCBMO on the polymer. AMMSCBMO also do not affect the constriction processes of the capsule around the silicone and its fragmentation. The thickness of the loose fibrous connective tissue around the encapsulated silicone with adsorbed AMMSCBMO less; along with this the capsule contains more blood vessels, compared with the condition after the introduction of the same foreign body, but without the use of cellular technologies. Conclusion. A smaller volume of loose fibrous connective tissue around the implanted silicone with AMMSCBMO indicates a decrease in the activity of the inflammatory response as a result of the use of cellular technologies, more rapid cleansing of the postoperative wound from debris, the success of reparative processes and the creation of conditions for the integration of a foreign body into the organism. It is likely all found effects associated with the presence of AMMSCBMO on silicone after its implantation to be caused not by AMMSCBMO themselves, but by their detritus, which in some cases may have a similar immunomodulatory effect with AMMSCBMO themselves or even exceed it.
Molekulyarnaya Meditsina (Molecular medicine). 2019;17(2):56-64
pages 56-64 views

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies